There is a growing demand for the sterilization of small-molecule parenteral products, including heart medications, eye drops, analgesics, and antibiotics, as well as intravenous solutions, such as glucose, potassium, and saline. To ensure patient safety, these drug products and related instruments commonly used in hospitals must be thoroughly sterilized after being manufactured. Known as "terminal sterilization," this highly efficient process ensures that no microbial contaminants like fungi or bacteria are present when the product is used.

If you have a product that needs to be terminally sterilized, we can help.

Proper formulation of active pharmaceutical ingredients (APIs) is essential for achieving therapeutic efficacy, ensuring patient safety, maintaining product stability, optimizing pharmacokinetics, meeting regulatory requirements, and enhancing cost-effectiveness in pharmaceutical development.

Altasciences' mission is to provide contract manufacturing services that simplify the logistics of your drug development programs, saving you time and money, and accelerating speed to market.

With our specialized support, you can be confident that your ophthalmic drug will not only meet regulatory standards but also address unmet medical needs in the most expedited manner possible.

Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions support programs from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.

Explore our collection of capabilities, including liquid-filled capsules, band/sealing technologies, powder, over-encapsulated capsules, topical formulations, and clinical and blister packaging.

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.

Altasciences' manufacturing experts give an overview of the facility, equipment, compound classification, and processes used for the development and handling of highly potent APIs.

Understand the benefits of partnering with a CRO/CDMO partner that has the drug development and manufacturing capabilities to seamlessly move compounds from one phase to the next.

Experts discuss the challenges they encounter in formulation development and tips on mitigating them to facilitate IND application and advance along the drug development pathway.

Formulation and pharmacy experts share their secrets for completing clinical trials and resolving issues that could impact your drug development program’s timeline.

Explore this comprehensive solution with both state-of-the-art equipment and unparalleled expertise, ensuring the successful execution of highly potent API projects.

Discover how scientists can effectively formulate poorly soluble drugs while reducing development time and costs.

Join Andrew Buis, senior formulation scientist, as he illustrates how the expertise and training of Altasciences' staff provide distinct advantages for their partners.

CDMO Services Vice President and Scientific Advisor Dennis DiBiagio talks about the development and manufacturing of drugs for central nervous system disorders, including mental disabilities.

Andrew Buis sheds light on the intricate yet transformative process of nanomilling, a technique that involves the pulverization and stabilization of particles.

Ensure that your API is meticulously tested and validated at every stage, facilitating a seamless transition from discovery and development to the final market-ready product.

Observe our experts in action as they scale up projects using a range of techniques and dosage forms, progressing from formulation to the production of commercial-scale batches.

Explore this contract manufacturing services offering designed to streamline drug development programs, resulting in time and cost savings while expediting the journey to market.

With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.

Altasciences is an award-winning, forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development.